Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Corrective Refractive Laser Surgeons (US)

Articles with lock require a subscription to GLG News | Request a free trial
September 18, 2008
Does Staar have an alternative to Lasik?
Analysis of: Insiders Buy Staar as Lasik Alternate Shows Potential (Update2) | www.bloomberg.com
Author: GLG Expert Contributor
The Staar ICL is a lens for the correction of high amounts of nearsightedness and will never take over a significant amount of the Lasik market. Their growth in the market for the ICL is in spite of the decrease in Lasik nationwide because more surgeons have been trained in its placement and because...
September 4, 2008
Laser is better than Steroids in the Management of Diabetic Macular Edema.
Analysis of: A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema | www.ophsource.org
Author: GLG Expert Contributor
This Phase III Clinical Trial clearly shows that focal grid laser is better than steroids in the management of Diabetic Macular Edema (DME).  This reaffirms laser as the current gold standard in the management of DME and casts doubts on numerous treatment modalities in the pipeline that use steroids...
Mark PackerAugust 19, 2008
Visian ICL: Premium Channel for the Extremely Nearsighted
Analysis of: Insiders Buy Staar as Lasik Alternate Shows Potential (Update2) | www.bloomberg.com
Author: Mark Packer, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC
The Visian ICL (Implantable Collamer Lens) is an exquisitely precise technology for the correction of high degrees of nearsightedness -- much higher than the reach of laser refractive surgery such as LASIK and PRK.  Given the price of the ICL and the intraocular surgey required for its...
Mark PackerJuly 21, 2008
Ultimately, the Patient, Not the Payor, is the Customer
Analysis of: Glaxo Seeks Guidance From Health Systems | online.wsj.com
Author: Mark Packer, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC
"He who pays the fiddler calls the tune."  Here's an example of the fiddler pro-actively asking the guy in the room with the deepest pocket what he'd like to hear.  If it's not something in the current repertoire, the fiddler seems willing to learn.  However, by the time he's got...
July 14, 2008
Avastin is inexpensive for Macular Degeneration therapy
Analysis of: Costly Cancer Drug Offers Hope, but Also a Dilemma | www.nytimes.com
Author: GLG Expert Contributor
I and many other ophthalmologists around the country use Avastin intravitreally for wet macular degeneration in doses far smaller than those used for systemic cancer.  Although it is an "off-label" use of the drug, the cost for using Avastin is 1/6oth of Lucentis, a very similar...
June 20, 2008
1st Chartless office in Tenn.
Analysis of: Most Doctors Aren’t Using Electronic Health Records | www.nytimes.com
Author: GLG Expert Contributor
I HAD THE 2ND CHARTLESS OFFICE IN THE SOUTHEAST THE 1ST IN TN. WHEN I 1ST OPENED MY OFFICE IN NASHVILLE IN 1991. ONCE IN YOU CAN NEVER GO BACK TO CHARTS; HOWEVER, THE COST ARE HIGH AND THE LEARNING CURVE IS SLOW. MOST DOC'S DON'T LIKE A CHANGE. THUS THE CONVERSION RATE WILL BE HIGHER IN DOCS STARTING...
June 5, 2008
Implications for Astigmatism
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
Author: GLG Expert Contributor
Many patients who have irregular astigmatism will find a disposable silicone hydrogel lens to provide good vision with less irritation of the cornea due to protein build up in the lens.  This could be a big help to those who may not be LASIK candidates or who are awaiting future Custom LASIK surgery...
May 14, 2008
Laser Refractive Surgery is Here to Stay
Analysis of: LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com
Author: GLG Expert Contributor
Although the lask procedure as the primary method of keratorefractive surery has been under scrutiny recently it remains the mainstay of refractive surgery.  With a 95% approval it is difficult to critisize its effectiveness. However the 5% patient complaints must be addressed.  The risk of...
May 7, 2008
LASIK IS AN EXCELLENT PROCEDURE FOR THE APPROPRIATE CANDIDATES
Analysis of: LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com
Author: GLG Expert Contributor
The FDA report and scrutiny of LASIK complaints reveals what consientious LASIK surgeons have known for years:  Not everyone who walks through your doors is a good lasik candidate and you should not laser everyone.  About 1 out of 4 patients that consider lasik are actually good candidates...
Mark PackerMay 6, 2008
Doubts About LASIK
Analysis of: LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com
Author: Mark Packer, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC
The media reporting on the FDA hearings on LASIK has generally highlighted unhappy patients' stories and the comments of FDA officials and panel members.  However, The Washington Post's Lauran Neergard has written an insightful article that foresees an important future trend in refractive surgery....

Page : 1 2 3 4 5 6 7 8 9 10 Next1 to 10 of 124

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-02T17:45:17.163